Marina De Smet Selected Research

Marina De Smet Research Topics

3	Type 2 Diabetes Mellitus (MODY) 11/2006 - 12/2005
2	Hypoglycemia (Reactive Hypoglycemia) 01/2006 - 12/2005
2	Vomiting 08/2003 - 06/2002
1	Thrombosis (Thrombus) 01/2017
1	Neoplasms (Cancer) 10/2015
1	Cardiotoxicity 12/2008
1	Nausea 08/2003

3	Sitagliptin Phosphate (Januvia)FDA Link 11/2006 - 12/2005
3	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2006 - 12/2005
2	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2006 - 01/2006
2	Neurokinin-1 Receptor AntagonistsIBA 08/2003 - 06/2002
2	Aprepitant (Emend)FDA Link 08/2003 - 06/2002
1	idarucizumabIBA 01/2017
1	prothrombin fragment 1IBA 01/2017
1	fibrin fragment D (D-dimer)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	BI 6727IBA 10/2015
1	Phosphotransferases (Kinase)IBA 10/2015
1	AfatinibIBA 10/2015
1	EtoricoxibIBA 12/2008
1	Digoxin (Digitek)FDA LinkGeneric 12/2008
1	Glucose (Dextrose)FDA LinkGeneric 11/2006
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2006
1	IncretinsIBA 11/2006
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 12/2005
1	AminesIBA 12/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2003
1	Cisplatin (Platino)FDA LinkGeneric 06/2002
1	Serotonin (5 Hydroxytryptamine)IBA 06/2002
1	TabletsIBA 06/2002
1	L 758298IBA 06/2002
1	Ondansetron (Zofran)FDA LinkGeneric 06/2002
1	AntiemeticsIBA 06/2002
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2002

1	Drug Therapy (Chemotherapy) 08/2003
1	Therapeutics 06/2002